RightAnswer Knowledge Solutions Search Results for 62-33-9

RightAnswer Knowledge Solutions provides access to hundreds of data sources. Our premier and proprietary sources include fully-researched documents from well-established experts in the chemical and HazMat fields.

A search in our system for this chemical would return results – all in one place -- in the following categories from the listed data sources.

---

RightAnswer Proprietary Data Sources:

---

All Other Data Sources:

---

ChemID External Links:

---

Other Government Links Searched via RegsKnowledge:

Example Content from MEDITEXT for 62-33-9:

Please note: this is an extract of information from a larger document. Full document and details are available by subscription.

ACUTE EXPOSURE INFORMATION

1. WITH THERAPEUTIC USE
   1. The following adverse effects have been reported with the use of edetate calcium disodium: Inverted T waves and cardiac rhythm irregularities, transient decreases in blood pressure, acute necrosis of the proximal tubules, microscopic hematuria, glycosuria, proteinuria, nephrotoxicity, acute renal failure, dermatitis and exfoliative dermatitis of the scrotum, injection site pain following intramuscular injection, hypocalcemia, hypercalcemia, nausea, vomiting, abdominal pain, diarrhea, mild elevations in SGOT and SGPT, anemia, bone marrow depression, fatigue, myalgia, zinc deficiency, headache, tremors, numbness, and tingling.
   2. In patients with lead encephalopathy, edetate calcium disodium may worsen cerebral edema. For patients with lead encephalopathy, edetate calcium disodium should be begun 4 hours after administration of dimercaprol.

2. WITH POISONING/EXPOSURE
   1. No ill effects were observed following inadvertent administration of 5 times the recommended dose, infused intravenously over a 24-hour period of time, to an asymptomatic 16-month-old with a blood lead level of 56 mcg/dL

© 2011-2025 RightAnswer.com, Inc. and/or its licensors. All rights reserved. No claim to original U.S. Govt. works.